6-32637511-T-C

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_002122.5(HLA-DQA1):​c.53T>C​(p.Met18Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00135 in 1,169,610 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.00028 ( 1 hom., cov: 15)
Exomes 𝑓: 0.0015 ( 20 hom. )

Consequence

HLA-DQA1
NM_002122.5 missense

Scores

2
14

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 1.01

Publications

7 publications found
Variant links:
Genes affected
HLA-DQA1 (HGNC:4942): (major histocompatibility complex, class II, DQ alpha 1) HLA-DQA1 belongs to the HLA class II alpha chain paralogues. The class II molecule is a heterodimer consisting of an alpha (DQA) and a beta chain (DQB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B Lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa. It is encoded by 5 exons; exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, and exon 4 encodes the transmembrane domain and the cytoplasmic tail. Within the DQ molecule both the alpha chain and the beta chain contain the polymorphisms specifying the peptide binding specificities, resulting in up to four different molecules. Typing for these polymorphisms is routinely done for bone marrow transplantation. [provided by RefSeq, Jul 2008]
HLA-DQA1-AS1 (HGNC:56667): (HLA-DQA1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0029515028).
BP6
Variant 6-32637511-T-C is Benign according to our data. Variant chr6-32637511-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 3341556.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAdExome4 at 20 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HLA-DQA1NM_002122.5 linkc.53T>C p.Met18Thr missense_variant Exon 1 of 5 ENST00000343139.11 NP_002113.2 P01909A0A173ADG5Q8MH44
HLA-DQA1XM_006715079.5 linkc.53T>C p.Met18Thr missense_variant Exon 1 of 4 XP_006715142.1
HLA-DQA1-AS1XR_007059544.1 linkn.2652A>G non_coding_transcript_exon_variant Exon 2 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HLA-DQA1ENST00000343139.11 linkc.53T>C p.Met18Thr missense_variant Exon 1 of 5 6 NM_002122.5 ENSP00000339398.5 P01909

Frequencies

GnomAD3 genomes
AF:
0.000278
AC:
28
AN:
100650
Hom.:
1
Cov.:
15
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00160
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00330
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00122
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000179
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0187
AC:
4530
AN:
241770
AF XY:
0.0180
show subpopulations
Gnomad AFR exome
AF:
0.00180
Gnomad AMR exome
AF:
0.00486
Gnomad ASJ exome
AF:
0.00317
Gnomad EAS exome
AF:
0.124
Gnomad FIN exome
AF:
0.0433
Gnomad NFE exome
AF:
0.00918
Gnomad OTH exome
AF:
0.0111
GnomAD4 exome
AF:
0.00145
AC:
1554
AN:
1068858
Hom.:
20
Cov.:
25
AF XY:
0.00155
AC XY:
834
AN XY:
538524
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000279
AC:
8
AN:
28664
American (AMR)
AF:
0.00156
AC:
55
AN:
35348
Ashkenazi Jewish (ASJ)
AF:
0.000835
AC:
16
AN:
19152
East Asian (EAS)
AF:
0.00771
AC:
221
AN:
28678
South Asian (SAS)
AF:
0.00162
AC:
117
AN:
72172
European-Finnish (FIN)
AF:
0.00361
AC:
163
AN:
45168
Middle Eastern (MID)
AF:
0.000272
AC:
1
AN:
3674
European-Non Finnish (NFE)
AF:
0.00117
AC:
923
AN:
791024
Other (OTH)
AF:
0.00111
AC:
50
AN:
44978
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.381
Heterozygous variant carriers
0
75
149
224
298
373
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000278
AC:
28
AN:
100752
Hom.:
1
Cov.:
15
AF XY:
0.000285
AC XY:
14
AN XY:
49154
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
29874
American (AMR)
AF:
0.00
AC:
0
AN:
8432
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2062
East Asian (EAS)
AF:
0.00331
AC:
10
AN:
3018
South Asian (SAS)
AF:
0.00
AC:
0
AN:
3190
European-Finnish (FIN)
AF:
0.00122
AC:
9
AN:
7352
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
152
European-Non Finnish (NFE)
AF:
0.000179
AC:
8
AN:
44718
Other (OTH)
AF:
0.00
AC:
0
AN:
1330
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.269
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00777
Hom.:
8
TwinsUK
AF:
0.0119
AC:
44
ALSPAC
AF:
0.0127
AC:
49
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00895
AC:
77
ExAC
AF:
0.0204
AC:
2482
Asia WGS
AF:
0.0430
AC:
151
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

HLA-DQA1: BP4, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
15
DANN
Benign
0.55
DEOGEN2
Benign
0.033
.;.;.;T;.
Eigen
Benign
-0.75
Eigen_PC
Benign
-0.81
FATHMM_MKL
Benign
0.018
N
LIST_S2
Benign
0.65
T;.;.;T;T
MetaRNN
Benign
0.0030
T;T;T;T;T
MetaSVM
Benign
-1.1
T
PhyloP100
1.0
PrimateAI
Benign
0.37
T
PROVEAN
Pathogenic
-5.5
D;N;N;N;N
REVEL
Benign
0.23
Sift
Benign
0.053
.;T;T;D;T
Sift4G
Pathogenic
0.0
D;D;D;D;D
Vest4
0.092, 0.14, 0.10
MPC
0.96
ClinPred
0.0093
T
GERP RS
3.0
PromoterAI
0.11
Neutral
gMVP
0.50
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11545686; hg19: chr6-32605288; COSMIC: COSV58242822; API